Avermectin B1a

CAS No. 65195-55-3

Avermectin B1a ( Abamectin B1a;Avamectin B1a )

Catalog No. M20980 CAS No. 65195-55-3

Avermectin B1a is a macrocyclic lactone disaccharide anthelmintic agent .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 38 Get Quote
50MG 52 Get Quote
100MG 67 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Avermectin B1a
  • Note
    Research use only not for human use.
  • Brief Description
    Avermectin B1a is a macrocyclic lactone disaccharide anthelmintic agent .
  • Description
    Avermectin B1a is a macrocyclic lactone disaccharide anthelmintic agent .
  • Synonyms
    Abamectin B1a;Avamectin B1a
  • Pathway
    Microbiology/Virology
  • Target
    Parasite
  • Recptor
    Parasite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65195-55-3
  • Formula Weight
    873.08
  • Molecular Formula
    C48H72O14
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (114.54 mM)
  • SMILES
    CCC(C)C1OC2(C=CC1C)CC1CC(C/C=C(\C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)/C=C/C=C3\COC4C(O)C(C)=CC(C(=O)O1)C34O)O2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Graham D Pfeiffer F Betz H . Avermectin B1a inhibits the binding of strychnine to the glycine receptor of rat spinal cord[J]. Neuroscience Letters 1982 29(2):173-176.
molnova catalog
related products
  • Diloxanide

    Diloxanide is an endomoeba insecticide. It is considered to be the luminal agent of choice for patients with mild enteroamoebiasis or asymptomatic cysts.

  • Tafenoquine

    Tafenoquine (SB-252263, Tafenoquine, WR 238605) is a long-acting, orally active anti-malarial agent to prevent malaria that is holoendemic for Plasmodium falciparum.

  • FR900098 sodium salt

    FR 900098 is a derivative of fosmidomycin that inhibits DOXP reductoisomerase, demonstrates antimalarial activity with IC50 of 170, 170, and 90 nM for HB3, A2, and Dd2 P. falciparum strains, respectively.